Abhishek Tripathi
Overview
Explore the profile of Abhishek Tripathi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
975
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tripathi A, Calabrese M, Pizzi A, Dhaka A, Demitri N, Turner D, et al.
Chem Asian J
. 2025 Feb;
:e202401846.
PMID: 39976574
Dichalcogenides are important intermediates in the catalytic cycle of the Glutathione peroxidase (GPx), the enzyme regulating the level of reactive oxygen species (ROS). Due to their redox sensitivity, dichalcogenides are...
2.
Choudhary R, Choudhary S, Tripathi A
World J Stem Cells
. 2024 Nov;
16(10):896-899.
PMID: 39493826
Recently, we read a mini-review published by Jeyaraman . The article explored the optimal methods for isolating mesenchymal stromal cells from adipose tissue-derived stromal vascular fraction (SVF). Key factors include...
3.
Jaime-Casas S, Tripathi A, Pal S, Yip W
Curr Urol Rep
. 2024 Oct;
26(1):11.
PMID: 39379745
Purpose Of Review: Upper tract urothelial carcinoma (UTUC) is an aggressive entity with treatment strategies mirroring bladder cancer. Genomic and molecular profiling allows for a better characterization of this disease...
4.
Gupta S, Shyamsundar K, Pushkar K, Agrawal M, Mishra A, Tripathi A, et al.
Med J Armed Forces India
. 2024 Sep;
80(5):560-565.
PMID: 39309579
Background: The aim of the study was to evaluate postoperative pupil distortion following small pupil cataract surgeries performed using B-HEX and Malyugin rings (MR). Methods: A randomized control trial was...
5.
Apolo A, Ballman K, Sonpavde G, Berg S, Kim W, Parikh R, et al.
N Engl J Med
. 2024 Sep;
392(1):45-55.
PMID: 39282902
Background: Muscle-invasive urothelial carcinoma is an aggressive disease with high rates of relapse. Whether pembrolizumab as adjuvant therapy would be effective in patients with high-risk muscle-invasive urothelial carcinoma after radical...
6.
Barata P, Tangen C, Plets M, Thompson Jr I, Narayan V, George D, et al.
J Clin Oncol
. 2024 Sep;
42(33):3911-3916.
PMID: 39255440
JCO Mesenchymal-epithelial transition (MET) signaling pathway plays a role in the pathogenesis of selected patients with papillary renal cell carcinoma (PRCC). In the phase II PAPMET trial (ClinicalTrials.gov identifier: NCT02761057),...
7.
Graham L, Henderson N, Kellezi O, Hwang C, Barata P, Bilen M, et al.
JCO Precis Oncol
. 2024 Aug;
8:e2400014.
PMID: 39178368
Purpose: Outcomes data for DNA-damaging therapeutics for men with prostate cancer (PC) and non- homologous recombination repair (HRR) mutations are limited. We evaluated outcomes by HRR alteration in men with...
8.
Gulati S, Tangen C, Ryan C, Vaishampayan U, Shuch B, Barata P, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2425288.
PMID: 39106067
Importance: Clinical trial data on adjuvant therapy in patients with non-clear cell renal cell carcinoma (RCC) are scant. Objective: To evaluate the effect of adjuvant everolimus after nephrectomy on recurrence-free...
9.
Broderick A, Pan E, Li J, Chu A, Hwang C, Barata P, et al.
Prostate Cancer Prostatic Dis
. 2024 Jul;
PMID: 39019980
Background: Aberrant Wnt signaling has been implicated in prostate cancer tumorigenesis and metastasis in preclinical models but the impact of genetic alterations in Wnt signaling genes in men with advanced...
10.
Tripathi A, Tangen C, Plets M, Li X, Tretiakova M, Humphrey P, et al.
BJU Int
. 2024 Jul;
134(4):596-601.
PMID: 39014969
Objective: To evaluate the clinical significance of subtyping (type 1 vs 2) of papillary renal cell carcinoma (PRCC) in patients treated with targeted therapy, as well as the concordance, sensitivity...